The European Medicines Agency has accepted Genzyme’s application for its multiple sclerosis pill teriflunomide. Genzyme, which is wholly owned by …
Sanofi-Aventis is to begin the first phase III study of an oral drug as an add-on to standard therapy in …
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer

